Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...
Medscape

MMR/MSI Testing for CRC Climbs, But Variations Persist

Testing for mismatch repair (MMR) and microsatellite instability (MSI) among patients with colorectal cancer (CRC) increased from 22.7% in 2012 to 71.5% in 2021, but variations in access remain, with ...
Business Wire

CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with Cancer

NORTHFIELD, Ill.--(BUSINESS WIRE)--Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP ...
Business Wire

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked & Available in Europe

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers LEIDEN, Netherlands & ...
Business Insider

Cancer Biomarkers Market for TMB, MSI / MMR and TILs is Projected to be Worth Over USD 860 Million by 2030, Growing at an Annualized Rate of 18.3%, Claims Roots Analysis

LONDON, Aug. 6, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019 – 2030" report to its list of offerings.
ascopubs.org

Overlooking MMR deficiency in carriers of certain pathogenic variants by routine MSI and/or IHC testing in Lynch syndrome: Implications for a wider MMR deficiency testing.

A novel xenonucleic acid mediated molecular clamping technology for early colorectal cancer diagnostics. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...
Healio

Study shows disparities in access to molecular diagnostics for colorectal cancer

Please provide your email address to receive an email when new articles are posted on . Although testing for microsatellite instability and mismatch repair deficiency has increased for advanced ...
News Medical

Genomic markers can predict lynch syndrome across tumor types

Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center ...